Intuitive Surgical Financial Statements (ISRG)
|
|
|
|
Report date
|
|
|
03.02.2022 |
10.02.2023 |
31.01.2024 |
31.01.2025 |
03.02.2026 |
|
22.04.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
5 710 |
6 222 |
7 124 |
8 352 |
10 065 |
|
10 582 |
|
Operating Income, bln rub |
|
|
1 821 |
1 577 |
1 767 |
2 349 |
2 946 |
|
3 223 |
|
EBITDA, bln rub |
? |
|
2 131 |
1 943 |
2 169 |
2 811 |
3 623 |
|
3 759 |
|
Net profit, bln rub |
? |
|
1 705 |
1 322 |
1 798 |
2 323 |
2 856 |
|
2 979 |
|
|
OCF, bln rub |
? |
|
2 089 |
1 491 |
1 814 |
2 415 |
3 031 |
|
3 361 |
|
CAPEX, bln rub |
? |
|
353.5 |
532.4 |
1 064 |
1 111 |
539.8 |
|
526.5 |
|
FCF, bln rub |
? |
|
1 736 |
958.4 |
749.6 |
1 304 |
2 491 |
|
2 834 |
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
OPEX, bln rub |
|
|
2 138 |
2 619 |
2 963 |
3 285 |
3 697 |
|
3 792 |
|
Cost of production, bln rub |
|
|
1 752 |
2 026 |
2 395 |
2 718 |
3 422 |
|
3 567 |
|
R&D, bln rub |
|
|
671.0 |
879.0 |
998.8 |
1 145 |
1 312 |
|
1 358 |
|
Interest expenses, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Assets, bln rub |
|
|
13 555 |
12 974 |
15 442 |
18 839 |
20 631 |
|
20 111 |
|
Net Assets, bln rub |
? |
|
11 952 |
11 042 |
13 308 |
16 434 |
17 824 |
|
17 475 |
|
Debt, bln rub |
|
|
87.0 |
0.000 |
0.000 |
146.0 |
302.8 |
|
0.000 |
|
Cash, bln rub |
|
|
4 231 |
4 118 |
5 223 |
4 013 |
5 935 |
|
4 548 |
|
Net debt, bln rub |
|
|
-4 144 |
-4 118 |
-5 223 |
-3 867 |
-5 632 |
|
-4 548 |
|
|
Ordinary share price, rub |
|
|
359.3 |
265.4 |
337.4 |
522.0 |
566.4 |
|
451.7 |
|
Number of ordinary shares, mln |
|
|
356.1 |
355.7 |
351.2 |
355.2 |
356.9 |
|
354.9 |
|
|
Market cap, bln rub |
|
|
127 947 |
94 385 |
118 481 |
185 400 |
202 134 |
|
160 319 |
|
EV, bln rub |
? |
|
123 803 |
90 267 |
113 258 |
181 533 |
196 502 |
|
155 771 |
|
Book value, bln rub |
|
|
11 537 |
10 644 |
12 920 |
16 063 |
17 443 |
|
16 688 |
|
|
EPS, rub |
? |
|
4.79 |
3.72 |
5.12 |
6.54 |
8.00 |
|
8.39 |
|
FCF/share, rub |
|
|
4.87 |
2.69 |
2.13 |
3.67 |
6.98 |
|
7.99 |
|
BV/share, rub |
|
|
32.4 |
29.9 |
36.8 |
45.2 |
48.9 |
|
47.0 |
|
|
EBITDA margin, % |
? |
|
37.3% |
31.2% |
30.4% |
33.7% |
36.0% |
|
35.5% |
|
Net margin, % |
? |
|
29.9% |
21.3% |
25.2% |
27.8% |
28.4% |
|
28.2% |
|
FCF yield, % |
? |
|
1.36% |
1.02% |
0.63% |
0.70% |
1.23% |
|
1.77% |
|
ROE, % |
? |
|
14.3% |
12.0% |
13.5% |
14.1% |
16.0% |
|
17.0% |
|
ROA, % |
? |
|
12.6% |
10.2% |
11.6% |
12.3% |
13.8% |
|
14.8% |
|
|
P/E |
? |
|
75.1 |
71.4 |
65.9 |
79.8 |
70.8 |
|
53.8 |
|
P/FCF |
|
|
73.7 |
98.5 |
158.1 |
142.2 |
81.2 |
|
56.6 |
|
P/S |
? |
|
22.4 |
15.2 |
16.6 |
22.2 |
20.1 |
|
15.2 |
|
P/BV |
? |
|
11.1 |
8.87 |
9.17 |
11.5 |
11.6 |
|
9.61 |
|
EV/EBITDA |
? |
|
58.1 |
46.5 |
52.2 |
64.6 |
54.2 |
|
41.4 |
|
Debt/EBITDA |
|
|
-1.94 |
-2.12 |
-2.41 |
-1.38 |
-1.55 |
|
-1.21 |
|
|
R&D/CAPEX, % |
|
|
189.8% |
165.1% |
93.9% |
103.1% |
243.0% |
|
257.8% |
|
|
CAPEX/Revenue, % |
|
|
6.19% |
8.56% |
14.9% |
13.3% |
5.36% |
|
4.98% |
|
| Intuitive Surgical shareholders |
